The Vault — Science and Medicine _□✕

Science and Medicine

CureVac COVID-19 vaccine

CureVac COVID-19 vaccine
CureVac COVID-19 vaccine

The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). The vaccine showed inadequate results in its Phase III trials with only 47% efficacy. In October 2021 CureVac abandoned further development and production plans for CVnCoV and refocused efforts on a cooperation with GlaxoSmithKline.

Also on this shelf

Attacks on health facilities during the Gaza war.

Israeli airstrikes on municipal services in the Gaza Strip.

See also

Uncatalogued shelf

Text from Wikipedia; plate via Wikimedia Commons. Text CC BY-SA 4.0; plate freely licensed (see Commons). Source record. Images and catalogue data are reproduced from open-access collections.

Depth 75
Shelf dcf67da738059c
25,934 catalogued holdings
3 ways on